Dr Reddys Laboratories
(for averaging purpose)
Mar-19 Mar 18 Mar-17 Mar-16 Mar-15 Mar-14
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital 83 83 82.9 85.3 85.2 85.1
Other Equity 12,601.10 11,724.80 11,517.70 11,520.10 10,548.80 9,243.90
Total Shareholders Funds 12,684.10 11,807.80 11,600.60 11,605.40 10,634.00 9,329.00
NON-CURRENT LIABILITIES
Long Term Borrowings 345.4 488 485.2 994.4 939.1 901.5
Other NC. Liab 138.7 84.6 103.4 159.1 204.3 163.4
CURRENT LIABILITIES
Short Term Borrowings 546.3 2,100.80 1,869.90 2,089.60 2,185.70 1,763.00
Trade Payables 1,031.60 1,061.00 778.7 719.2 716 842.3
Other Current Liabilities 1,316.70 1,384.70 1,401.00 1,409.50 1,237.40 1,029.40
Short Term Provisions 184.7 173.4 208.4 580.4 539.5 479.5
Total Current Liabilities 3,079.30 4,719.90 4,258.00 4,798.70 4,678.60 4,114.20
Total Capital And Liabilities 16,247.50 17,100.30 16,447.20 17,557.60 16,456.00 14,508.10
ASSETS
NON-CURRENT ASSETS
Tangible Assets 3,950.40 3,979.00 4,043.30 3,593.80 3,129.40 2,693.70
Intangible Assets 732.3 738.3 798.8 835.5 120 54.6
Capital Work-In-Progress 400.1 675 540 615 488.3 576.1
Total Fixed Assets 5,082.80 5,392.30 5,382.10 5,044.30 3,737.70 3,324.40
Non-Current Investments 1,819.10 1,953.70 1,802.80 1,776.10 1,760.10 1,740.10
Deferred Tax Assets [Net] 0 93.1 82.1 0 0 0
Long Term Loans And Advances 33.2 199.1 193.2 639.6 553.8 535.8
Other Non-Current Assets 379.2 423.6 393.2 2.7 1.1 0
Total Non-Current Assets 7,314.30 8,061.80 7,853.40 7,462.70 6,052.70 5,600.30
CURRENT ASSETS
Current Investments 2,114.40 1,682.80 1,299.10 2,112.20 2,102.20 1,066.40
Inventories 2,015.60 1,856.80 1,809.70 1,699.60 1,723.30 1,592.10
Trade Receivables 3,717.70 4,203.80 4,405.40 3,893.50 4,711.70 4,561.50
Cash And Cash Equivalents 113.2 120.7 66.8 1,268.00 901.4 665.1
Other Current Assets 972.3 1,174.40 1,012.80 1,121.60 964.70 1,022.70
Total Current Assets 8,933.20 9,038.50 8,593.80 10,094.90 10,403.30 8,907.80
Total Assets 16,247.50 17,100.30 16,447.20 17,557.60 16,456.00 14,508.10
ng purpose)
Mar-19 Mar 18 Mar-17 Mar-16 Mar-15 Mar-14
INCOME
Revenue From Operations 10,572.90 9,302.60 9,628.10 10,150.60 9,927.50 9,646.80
Other Operating Revenues 52.6 56.7 91.7 57.1 83.5 81.2
Total Operating Revenues 10,625.50 9,359.30 9,719.80 10,207.70 10,011.00 9,728.00
Other Income 238.4 204 591.2 244.8 222.8 151.5
Total Revenue 10,863.90 9,563.30 10,311.00 10,452.50 10,233.80 9,879.50
EXPENSES
Cost Of Materials Consumed 2,103.20 2,011.00 1,904.60 1,988.50 2,248.40 2,191.80
Purchase Of Stock-In Trade 868.6 671.6 671.5 610.4 526.1 469
other dirct exp 0 0 0 94.2 92.4 78.5
Changes inventory 66 -51.6 1.9 -28.8 -28.9 -114.4
Employee Benefit Expenses 1,931.90 1,843.00 1,803.30 1,710.00 1,490.90 1,184.90
Finance Costs 56.8 62.8 57.2 63.8 63.8 78.3
Depreciation And Amortisation 780.6 774.1 735.1 649.1 490.2 380.5
Other Expenses 3,356.10 3,555.40 3,592.90 3,429.40 3,291.00 3,156.50
Total Expenses 9,163.20 8,866.30 8,766.50 8,516.60 8,173.90 7,425.10
EBIT & Excetpional items 1,700.70 697 1,544.50 1,935.90 2,059.90 2,454.40
Exceptional Items 0 0 0 -355.9 0 0
Profit/Loss Before Tax 1,700.70 697 1,544.50 1,580.00 2,059.90 2,454.40
Total Income Tax Expenses 423.4 130.1 160.4 225.5 380.5 521.6
Profit/Loss For The Period 1,277.30 566.9 1,384.10 1,354.50 1,679.40 1,932.80
P&L Excluding Exceptional 1,277.30 566.9 1384.1 1710.4 1679.4 1932.8
Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Profitability Ratios
Profit Margin 12.08% 6.09% 14.38% 16.85% 16.92% 20.04%
Return on Asset 7.66% 3.38% 8.14% 10.06% 10.85% 13.32%
Return on Equity 10.43% 4.84% 11.93% 15.38% 16.83% 20.72%
Asset Management Ratio
Total Asset Turnover 63.41% 55.46% 56.63% 59.69% 64.12% 66.493%
Fixed Asset Turnover 201.87% 172.68% 184.69% 231.17% 281.15% 290.182%
Inventory Turnover 247.10% 236.01% 240.20% 243.56% 245.74%
Receivables Turnover 266.94% 216.11% 232.03% 235.92% 214.11% 211.483%
Liquidity Ratio
Current Ratio 290.10% 191.50% 201.83% 210.37% 222.36% 216.51%
Quick Ratio 224.65% 152.16% 159.33% 174.95% 185.53% 177.82%
Solvency ratio
Debt-to-equity Ratio 7.030% 21.924% 20.302% 26.574% 29.385% 28.561%
Liabilities to equity Ratio 28.093% 44.822% 41.779% 51.288% 54.749% 55.516%
Interest Coverage Ratio 30.9419014084507 12.098726115 28.001748252 31.343260188 33.286833856 32.346104725